BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34046124)

  • 21. Membranoproliferative glomerulonephritis in Russian population.
    Dobronravov VA; Smirnov AV
    Ter Arkh; 2018 Dec; 90(12):39-47. PubMed ID: 30701832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis.
    Çaltik Yilmaz A; Aydog Ö; Akyüz SG; Bülbül M; Demircin G; Öner A
    Ren Fail; 2014 Sep; 36(8):1221-5. PubMed ID: 25065413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
    Caravaca-Fontán F; Polanco N; Villacorta B; Buxeda A; Coca A; Ávila A; Martínez-Gallardo R; Galeano C; Valero R; Ramos N; Allende N; Cruzado-Vega L; Pérez-Sáez MJ; Sevillano Á; González E; Hernández A; Rodrigo E; Fernández-Ruiz M; Aguado JM; Pérez Valdivia MÁ; Pascuall J; Andrés A; Praga M;
    Nephrol Dial Transplant; 2023 Jan; 38(1):222-235. PubMed ID: 35404425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Factors predicting chronic renal failure in membranoproliferative glomerulonephritis].
    Dobronravov VA
    Klin Med (Mosk); 1996; 74(7):29-33. PubMed ID: 8992108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis.
    Kawasaki Y; Kanno S; Ono A; Suzuki Y; Ohara S; Sato M; Suyama K; Hashimoto K; Hosoya M
    Pediatr Nephrol; 2016 Jul; 31(7):1091-9. PubMed ID: 26846787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.
    Angelo JR; Bell CS; Braun MC
    Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
    Abreo K; Moorthy AV
    Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.
    Nakagawa N; Mizuno M; Kato S; Maruyama S; Sato H; Nakaya I; Sugiyama H; Fujimoto S; Miura K; Matsumura C; Gotoh Y; Suzuki H; Kuroki A; Yoshino A; Nakatani S; Hiromura K; Yamamoto R; Yokoyama H; Narita I; Isaka Y
    PLoS One; 2021; 16(9):e0257397. PubMed ID: 34520493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent Glomerulonephritis in Renal Transplantation: Experience in Our Renal Transplantation Center.
    Cañas L; López D; Pérez JF; Bancu I; Juega J; Ariza A; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2354-6. PubMed ID: 26518925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.
    Nakano M; Karasawa K; Moriyama T; Uchida K; Nitta K
    Clin Exp Nephrol; 2019 Jun; 23(6):852-858. PubMed ID: 30854618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature.
    Java A; Gaut JP; Brennan DC
    Transpl Int; 2012 May; 25(5):e58-61. PubMed ID: 22380572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)].
    Riabov SI; Dobronravov VA
    Ter Arkh; 1994; 66(6):15-8. PubMed ID: 7940356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.
    Nakagawa N; Hasebe N; Hattori M; Nagata M; Yokoyama H; Sato H; Sugiyama H; Shimizu A; Isaka Y; Maruyama S; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):797-807. PubMed ID: 29214407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
    Iatropoulos P; Noris M; Mele C; Piras R; Valoti E; Bresin E; Curreri M; Mondo E; Zito A; Gamba S; Bettoni S; Murer L; Fremeaux-Bacchi V; Vivarelli M; Emma F; Daina E; Remuzzi G
    Mol Immunol; 2016 Mar; 71():131-142. PubMed ID: 26895476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
    Ueda H; Isimura E; Okuno S; Maekawa K; Izumotani T; Kim M; Matsumoto N; Fukumoto S; Imanishi Y; Emoto M; Shoji T; Wanibuchi H; Inaba M; Nishizawa Y
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):420-6. PubMed ID: 12073629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interstitial foam cells in renal biopsies: an aid in differentiating idiopathic membranoproliferative glomerulonephritis (type I) and membranoproliferative glomerulonephritis associated with systemic lupus erythematosus.
    Poucell S; Thorner P; Balfe JW; Baumal R
    Child Nephrol Urol; 1988-1989; 9(1-2):106-11. PubMed ID: 3251613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury.
    Andeen NK; Jefferson JA; Akilesh S; Alpers CE; Bissonnette ML; Finn LS; Higgins J; Houghton DC; Kambham N; Magil A; Najafian B; Nicosia RF; Troxell ML; Smith KD
    Hum Pathol; 2018 Nov; 81():272-280. PubMed ID: 30420049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.